InsidersTradesSigma
Follow the Medlive Technology Co., Ltd. stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Operating in the Technology sector, Medlive Technology Co., Ltd. has recorded 3 public disclosures. Market capitalisation: €5.8bn. The latest transaction was filed on 9 April 2026 (Other). Among the most active insiders: Tian Lijun. Every trade is accessible without an account.
Analysts rate Medlive Technology Co., Ltd. Strong Buy (bullish), based on 5 analysts. Average price target: HK$12.61.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Medlive Technology Co., Ltd. 是一家专注于为医疗保健领域开发技术解决方案的公司。该公司在香港证券交易所上市。